A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver …
F Moradi, F Kooshki, F Nokhostin, M Khoshbaten… - Journal of Trace …, 2021 - Elsevier
Background Evaluating the impact of chromium picolinate supplementation on glycemic
status, lipid profile, inflammatory markers and fetuin-A in patients with non-alcoholic fatty …
status, lipid profile, inflammatory markers and fetuin-A in patients with non-alcoholic fatty …
Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
F Kooshki, F Moradi, A Karimi, HR Niazkar… - European Journal of …, 2021 - journals.lww.com
Objective Nonalcoholic fatty liver disease (NAFLD) is a complicated disease and is
considered as a severe global health problem affecting 30% of adults worldwide. The …
considered as a severe global health problem affecting 30% of adults worldwide. The …
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and …
SK Jain, JL Croad, T Velusamy… - Molecular nutrition & …, 2010 - Wiley Online Library
Chromium and cysteine supplementation can improve glucose metabolism in animal
studies. This study examined the hypothesis that a cysteinate complex of chromium is …
studies. This study examined the hypothesis that a cysteinate complex of chromium is …
Higher serum chromium level may be associated with the presentation of depression in patients with metabolic dysfunction-associated fatty liver disease: evidence …
X Li, X Xia, B Jiang, Y Yao, F Ding, S Qin - Frontiers in Psychiatry, 2024 - frontiersin.org
Background Depressive symptoms are frequently observed in patients with Metabolic
Dysfunction-Associated Fatty Liver Disease (MAFLD), a prevalent metabolic disorder that …
Dysfunction-Associated Fatty Liver Disease (MAFLD), a prevalent metabolic disorder that …
Effect of chromium supplementation on blood glucose, hemoglobin A1c, lipid profile and lipid peroxidation in type 2 diabetic patients
N Parsaeyan, KH MOZAFFARI - 2012 - sid.ir
Objective: Type 2 diabetes mellitus is a complex metabolic disorder with adverse
cardiovascular risk. Chromium is an essential nutrient and its role in carbohydrate and lipid …
cardiovascular risk. Chromium is an essential nutrient and its role in carbohydrate and lipid …
[PDF][PDF] Effect of chromium supplementation on glucose tolerance and lipid profile
SM Bahijri - Saudi medical journal, 2000 - academia.edu
Objectives: To investigate chromium status of the adult population in the western region of
Saudi Arabia and the possibility of using serum chromium status measurement as indicator …
Saudi Arabia and the possibility of using serum chromium status measurement as indicator …
Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice
WY Chen, CJ Chen, CH Liu, FC Mao - Biochemical and biophysical …, 2010 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with insulin
resistance, oxidative stress, and inflammation. Evidence indicates that chromium has a role …
resistance, oxidative stress, and inflammation. Evidence indicates that chromium has a role …
Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes
S Sharma, RP Agrawal, M Choudhary, S Jain… - Journal of Trace …, 2011 - Elsevier
PROJECT: Chromium is an essential nutrient involved in normal carbohydrate and lipid
metabolism. It influences glucose metabolism by potentiating the action as taking part in …
metabolism. It influences glucose metabolism by potentiating the action as taking part in …
Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded …
J Geohas, A Daly, V Juturu, M Finch… - The American journal of …, 2007 - Elsevier
Background The atherogenic index of plasma (AIP), defined as logarithm [log] of the ratio of
plasma concentration of triglycerides to high-density lipoprotein (HDL) cholesterol, has …
plasma concentration of triglycerides to high-density lipoprotein (HDL) cholesterol, has …
The effects of chromium supplementation on lipidprofile in humans: A systematic review and meta-analysis ofrandomized controlled trials
Background and aim This systematic review and meta-analysis aimed to evaluate the effects
of chromium supplementation on lipid profile consisting of total cholesterol (TC), triglyceride …
of chromium supplementation on lipid profile consisting of total cholesterol (TC), triglyceride …
相关搜索
- chromium supplementation lipid profile
- chromium supplementation meta analysis
- liver disease high fat
- chromium supplementation beneficial effect
- chromium supplementation diabetic patients
- chromium supplementation hemoglobin a1c
- chromium supplementation blood glucose
- chromium supplementation dose response
- liver disease hlj mice
- chromium supplementation lipid variables
- chromium supplementation glucose tolerance
- chromium supplementation lipid peroxidation